Table 1

Patients with AIG: demographics and clinicopathological profile

VariableT1
211 patients
Female
160 (75.8%)
Male
51 (24.2%)
T2
211 patients
Female
160 (75.8%)
Male
51 (24.2%)
Age: Mean (SD); median55.7 (1 4.1); 5654.5 (14.3); 5559.7 (13.0); 6363.3 (13.3); 6462.2 (13.5); 6266.5 (12.5); 67
H. pylori status (serology, histology, molecular biology on tissue samples)All negative16051All negative16051
Follow-up (years): mean (SD); median7.5 (4.4); 77.7 (4.5); 77.0 (4.1); 6
OLGA staging
 08 (3.8%)807 (3.3%)61
 I23 (10.9%)19419 (9.0%)163
 II179 (84.8%)13247175 (82.9%)12946
 III1 (0.5%)1010 (4.7%)91
 IV000000
IEN
 Absent210209
 Low grade1 (FAP)2 (1 FAP)
 High grade00
ECL status
 Within normal limits2015524195
 Diffuse hyperplasia linear/micronodular1671303715110942
 Adenomatoid hyperplasia/dysplasia1411325223
 Type1-NET104611101
  • ECL, enterochromaffin like cells; FAP, familial adenomatous polyposis; IEN, intraepithelial neoplasia; T1, time of the index biopsy set; T2, time of the last check-up; Type1-NET, type 1 neuroendocrine tumours.